Understand the role of free light chains in plasma cell disorders
Learn how FLC testing supports the diagnosis, prognosis, and monitoring of multiple myeloma and other paraprotein-related diseases.
In this 60-minute webinar, Pr. Oliver Frey will notably:
Learn how FLC testing supports the diagnosis, prognosis, and monitoring of multiple myeloma and other paraprotein-related diseases.
Explore the technical and methodological differences between available assays, including the impact of reference intervals and chronic kidney disease (CKD) on result interpretation.
Gain practical insights into assay switching, clinical performance considerations, and strategies to ensure consistent patient monitoring and accurate clinical decision-making.
The free light chains are now a biomarker of malignancy
Pr. Oliver Frey is a specialist in laboratory medicine.
He is medical director of the IMD Berlin MVZ and specializes in immunological diagnostics and the diagnosis of hematological neoplasia.
Pr. Frey is also involved in accreditation procedures as an expert assessor in the field of immunology and is committed to quality-assured, precise and patient-centered medical diagnostics.

Educational Webinar with Janetta Bryksin, PhD, DABCC, FADLM
Educational Webinar with Raquel Yahyaoui
This section contains information intended for wide distribution and may therefore contain product details or information that is not available or valid in your country. Please contact your local Sebia representative. Information intended for healthcare professionals. Carefully read the instructions in the reagent package inserts and instrument manuals.